USE OF SERTINDOLE FOR THE PREVENTIVE TREATMENT OF SUICIDAL BEHAVIOUR
1 Assignment
0 Petitions
Accused Products
Abstract
The present invention relates to the use of sertindole in the preparation of a pharmaceutical composition for the preventive treatment of suicidal behaviour in human subjects suffering from a psychotic illness such as schizophrenia or schizoaffective psychosis.
-
Citations
28 Claims
-
1. (canceled)
-
12. A therapeutic package comprising:
-
(a) a dosage form of sertindole in one or more unit doses, wherein each unit dose comprises an amount of sertindole effective in treating the patient'"'"'s suicidal behavior. (b) a finished pharmaceutical container containing the unit doses of sertindole;
(c) written matter associated with the therapeutic package stating that the dosage form can be administered to treat a suicidal behavior in a human subject suffering from a psychotic illness. (d) an optional outside container or wrapper. - View Dependent Claims (14, 15, 18, 25, 26, 27, 28)
-
-
13. (canceled)
- 16. A method for marketing sertindole comprising the step of marketing sertindole for the treatment of suicidal behavior in human subjects suffering from a psychotic illness.
- 17. A method of treating a suicidal behavior in a human subject suffering from a psychotic illness, which comprises administering to said human subject an effective amount of a pharmaceutical composition comprising sertindole.
Specification